Global Pancreatic Beta-Cell Protection Market Insights and Forecast to 2028

Publisher Name :
Date: 03-Feb-2022
No. of pages: 117
Inquire Before Buying

Pancreatic Beta-Cell Protection market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pancreatic Beta-Cell Protection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Stem Cell Based

- Gene Therapies

- RNA Based Therapies

- Monoclonal Antibodies (MAbs)

- Phytotherapy

Segment by Application

- Hospital

- Medical Research Laboratory

- Others

By Company

- ViaCyte

- PharmaCyte Biotech

- Boehringer Ingelheim

- GalaxoSmithKline

- Beta-Cell NV

- Novartis

- Janssen Research & Development

- Pfizer Inc

- BioLineRx

- Genentech

- Novo Nordisk

- Sanofi

- Osiris Therapeutics

- Beta-O2 Technologies Ltd

- Transition Therapeutics

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Pancreatic Beta-Cell Protection Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stem Cell Based
1.2.3 Gene Therapies
1.2.4 RNA Based Therapies
1.2.5 Monoclonal Antibodies (MAbs)
1.2.6 Phytotherapy
1.3 Market by Application
1.3.1 Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pancreatic Beta-Cell Protection Market Perspective (2017-2028)
2.2 Pancreatic Beta-Cell Protection Growth Trends by Region
2.2.1 Pancreatic Beta-Cell Protection Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pancreatic Beta-Cell Protection Historic Market Size by Region (2017-2022)
2.2.3 Pancreatic Beta-Cell Protection Forecasted Market Size by Region (2023-2028)
2.3 Pancreatic Beta-Cell Protection Market Dynamics
2.3.1 Pancreatic Beta-Cell Protection Industry Trends
2.3.2 Pancreatic Beta-Cell Protection Market Drivers
2.3.3 Pancreatic Beta-Cell Protection Market Challenges
2.3.4 Pancreatic Beta-Cell Protection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue
3.1.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue (2017-2022)
3.1.2 Global Pancreatic Beta-Cell Protection Revenue Market Share by Players (2017-2022)
3.2 Global Pancreatic Beta-Cell Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pancreatic Beta-Cell Protection Revenue
3.4 Global Pancreatic Beta-Cell Protection Market Concentration Ratio
3.4.1 Global Pancreatic Beta-Cell Protection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Beta-Cell Protection Revenue in 2021
3.5 Pancreatic Beta-Cell Protection Key Players Head office and Area Served
3.6 Key Players Pancreatic Beta-Cell Protection Product Solution and Service
3.7 Date of Enter into Pancreatic Beta-Cell Protection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pancreatic Beta-Cell Protection Breakdown Data by Type
4.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Type (2017-2022)
4.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2023-2028)
5 Pancreatic Beta-Cell Protection Breakdown Data by Application
5.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Application (2017-2022)
5.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pancreatic Beta-Cell Protection Market Size (2017-2028)
6.2 North America Pancreatic Beta-Cell Protection Market Size by Type
6.2.1 North America Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
6.2.2 North America Pancreatic Beta-Cell Protection Market Size by Type (2023-2028)
6.2.3 North America Pancreatic Beta-Cell Protection Market Share by Type (2017-2028)
6.3 North America Pancreatic Beta-Cell Protection Market Size by Application
6.3.1 North America Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
6.3.2 North America Pancreatic Beta-Cell Protection Market Size by Application (2023-2028)
6.3.3 North America Pancreatic Beta-Cell Protection Market Share by Application (2017-2028)
6.4 North America Pancreatic Beta-Cell Protection Market Size by Country
6.4.1 North America Pancreatic Beta-Cell Protection Market Size by Country (2017-2022)
6.4.2 North America Pancreatic Beta-Cell Protection Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pancreatic Beta-Cell Protection Market Size (2017-2028)
7.2 Europe Pancreatic Beta-Cell Protection Market Size by Type
7.2.1 Europe Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
7.2.2 Europe Pancreatic Beta-Cell Protection Market Size by Type (2023-2028)
7.2.3 Europe Pancreatic Beta-Cell Protection Market Share by Type (2017-2028)
7.3 Europe Pancreatic Beta-Cell Protection Market Size by Application
7.3.1 Europe Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
7.3.2 Europe Pancreatic Beta-Cell Protection Market Size by Application (2023-2028)
7.3.3 Europe Pancreatic Beta-Cell Protection Market Share by Application (2017-2028)
7.4 Europe Pancreatic Beta-Cell Protection Market Size by Country
7.4.1 Europe Pancreatic Beta-Cell Protection Market Size by Country (2017-2022)
7.4.2 Europe Pancreatic Beta-Cell Protection Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size (2017-2028)
8.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type
8.2.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Type (2017-2028)
8.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application
8.3.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Application (2017-2028)
8.4 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region
8.4.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pancreatic Beta-Cell Protection Market Size (2017-2028)
9.2 Latin America Pancreatic Beta-Cell Protection Market Size by Type
9.2.1 Latin America Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
9.2.2 Latin America Pancreatic Beta-Cell Protection Market Size by Type (2023-2028)
9.2.3 Latin America Pancreatic Beta-Cell Protection Market Share by Type (2017-2028)
9.3 Latin America Pancreatic Beta-Cell Protection Market Size by Application
9.3.1 Latin America Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
9.3.2 Latin America Pancreatic Beta-Cell Protection Market Size by Application (2023-2028)
9.3.3 Latin America Pancreatic Beta-Cell Protection Market Share by Application (2017-2028)
9.4 Latin America Pancreatic Beta-Cell Protection Market Size by Country
9.4.1 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2017-2022)
9.4.2 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size (2017-2028)
10.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type
10.2.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Type (2017-2028)
10.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application
10.3.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Application (2017-2028)
10.4 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country
10.4.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ViaCyte
11.1.1 ViaCyte Company Details
11.1.2 ViaCyte Business Overview
11.1.3 ViaCyte Pancreatic Beta-Cell Protection Introduction
11.1.4 ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.1.5 ViaCyte Recent Developments
11.2 PharmaCyte Biotech
11.2.1 PharmaCyte Biotech Company Details
11.2.2 PharmaCyte Biotech Business Overview
11.2.3 PharmaCyte Biotech Pancreatic Beta-Cell Protection Introduction
11.2.4 PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.2.5 PharmaCyte Biotech Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Pancreatic Beta-Cell Protection Introduction
11.3.4 Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.3.5 Boehringer Ingelheim Recent Developments
11.4 GalaxoSmithKline
11.4.1 GalaxoSmithKline Company Details
11.4.2 GalaxoSmithKline Business Overview
11.4.3 GalaxoSmithKline Pancreatic Beta-Cell Protection Introduction
11.4.4 GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.4.5 GalaxoSmithKline Recent Developments
11.5 Beta-Cell NV
11.5.1 Beta-Cell NV Company Details
11.5.2 Beta-Cell NV Business Overview
11.5.3 Beta-Cell NV Pancreatic Beta-Cell Protection Introduction
11.5.4 Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.5.5 Beta-Cell NV Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Pancreatic Beta-Cell Protection Introduction
11.6.4 Novartis Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.6.5 Novartis Recent Developments
11.7 Janssen Research & Development
11.7.1 Janssen Research & Development Company Details
11.7.2 Janssen Research & Development Business Overview
11.7.3 Janssen Research & Development Pancreatic Beta-Cell Protection Introduction
11.7.4 Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.7.5 Janssen Research & Development Recent Developments
11.8 Pfizer Inc
11.8.1 Pfizer Inc Company Details
11.8.2 Pfizer Inc Business Overview
11.8.3 Pfizer Inc Pancreatic Beta-Cell Protection Introduction
11.8.4 Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.8.5 Pfizer Inc Recent Developments
11.9 BioLineRx
11.9.1 BioLineRx Company Details
11.9.2 BioLineRx Business Overview
11.9.3 BioLineRx Pancreatic Beta-Cell Protection Introduction
11.9.4 BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.9.5 BioLineRx Recent Developments
11.10 Genentech
11.10.1 Genentech Company Details
11.10.2 Genentech Business Overview
11.10.3 Genentech Pancreatic Beta-Cell Protection Introduction
11.10.4 Genentech Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.10.5 Genentech Recent Developments
11.11 Novo Nordisk
11.11.1 Novo Nordisk Company Details
11.11.2 Novo Nordisk Business Overview
11.11.3 Novo Nordisk Pancreatic Beta-Cell Protection Introduction
11.11.4 Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.11.5 Novo Nordisk Recent Developments
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Pancreatic Beta-Cell Protection Introduction
11.12.4 Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.12.5 Sanofi Recent Developments
11.13 Osiris Therapeutics
11.13.1 Osiris Therapeutics Company Details
11.13.2 Osiris Therapeutics Business Overview
11.13.3 Osiris Therapeutics Pancreatic Beta-Cell Protection Introduction
11.13.4 Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.13.5 Osiris Therapeutics Recent Developments
11.14 Beta-O2 Technologies Ltd
11.14.1 Beta-O2 Technologies Ltd Company Details
11.14.2 Beta-O2 Technologies Ltd Business Overview
11.14.3 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Introduction
11.14.4 Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.14.5 Beta-O2 Technologies Ltd Recent Developments
11.15 Transition Therapeutics
11.15.1 Transition Therapeutics Company Details
11.15.2 Transition Therapeutics Business Overview
11.15.3 Transition Therapeutics Pancreatic Beta-Cell Protection Introduction
11.15.4 Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
11.15.5 Transition Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Stem Cell Based
Table 3. Key Players of Gene Therapies
Table 4. Key Players of RNA Based Therapies
Table 5. Key Players of Monoclonal Antibodies (MAbs)
Table 6. Key Players of Phytotherapy
Table 7. Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Pancreatic Beta-Cell Protection Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Pancreatic Beta-Cell Protection Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Pancreatic Beta-Cell Protection Market Share by Region (2017-2022)
Table 11. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Pancreatic Beta-Cell Protection Market Share by Region (2023-2028)
Table 13. Pancreatic Beta-Cell Protection Market Trends
Table 14. Pancreatic Beta-Cell Protection Market Drivers
Table 15. Pancreatic Beta-Cell Protection Market Challenges
Table 16. Pancreatic Beta-Cell Protection Market Restraints
Table 17. Global Pancreatic Beta-Cell Protection Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Pancreatic Beta-Cell Protection Revenue Share by Players (2017-2022)
Table 19. Global Top Pancreatic Beta-Cell Protection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Beta-Cell Protection as of 2021)
Table 20. Ranking of Global Top Pancreatic Beta-Cell Protection Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Pancreatic Beta-Cell Protection Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pancreatic Beta-Cell Protection Product Solution and Service
Table 24. Date of Enter into Pancreatic Beta-Cell Protection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2017-2022)
Table 28. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2023-2028)
Table 30. Global Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Pancreatic Beta-Cell Protection Revenue Share by Application (2017-2022)
Table 32. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Pancreatic Beta-Cell Protection Revenue Share by Application (2023-2028)
Table 34. North America Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Pancreatic Beta-Cell Protection Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Pancreatic Beta-Cell Protection Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Pancreatic Beta-Cell Protection Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Pancreatic Beta-Cell Protection Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Pancreatic Beta-Cell Protection Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Pancreatic Beta-Cell Protection Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Pancreatic Beta-Cell Protection Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Pancreatic Beta-Cell Protection Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Pancreatic Beta-Cell Protection Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Pancreatic Beta-Cell Protection Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Pancreatic Beta-Cell Protection Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Pancreatic Beta-Cell Protection Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Pancreatic Beta-Cell Protection Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Pancreatic Beta-Cell Protection Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Pancreatic Beta-Cell Protection Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Pancreatic Beta-Cell Protection Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Pancreatic Beta-Cell Protection Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Pancreatic Beta-Cell Protection Market Size by Country (2023-2028) & (US$ Million)
Table 64. ViaCyte Company Details
Table 65. ViaCyte Business Overview
Table 66. ViaCyte Pancreatic Beta-Cell Protection Product
Table 67. ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 68. ViaCyte Recent Developments
Table 69. PharmaCyte Biotech Company Details
Table 70. PharmaCyte Biotech Business Overview
Table 71. PharmaCyte Biotech Pancreatic Beta-Cell Protection Product
Table 72. PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 73. PharmaCyte Biotech Recent Developments
Table 74. Boehringer Ingelheim Company Details
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim Pancreatic Beta-Cell Protection Product
Table 77. Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Developments
Table 79. GalaxoSmithKline Company Details
Table 80. GalaxoSmithKline Business Overview
Table 81. GalaxoSmithKline Pancreatic Beta-Cell Protection Product
Table 82. GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 83. GalaxoSmithKline Recent Developments
Table 84. Beta-Cell NV Company Details
Table 85. Beta-Cell NV Business Overview
Table 86. Beta-Cell NV Pancreatic Beta-Cell Protection Product
Table 87. Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 88. Beta-Cell NV Recent Developments
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Pancreatic Beta-Cell Protection Product
Table 92. Novartis Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 93. Novartis Recent Developments
Table 94. Janssen Research & Development Company Details
Table 95. Janssen Research & Development Business Overview
Table 96. Janssen Research & Development Pancreatic Beta-Cell Protection Product
Table 97. Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 98. Janssen Research & Development Recent Developments
Table 99. Pfizer Inc Company Details
Table 100. Pfizer Inc Business Overview
Table 101. Pfizer Inc Pancreatic Beta-Cell Protection Product
Table 102. Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 103. Pfizer Inc Recent Developments
Table 104. BioLineRx Company Details
Table 105. BioLineRx Business Overview
Table 106. BioLineRx Pancreatic Beta-Cell Protection Product
Table 107. BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 108. BioLineRx Recent Developments
Table 109. Genentech Company Details
Table 110. Genentech Business Overview
Table 111. Genentech Pancreatic Beta-Cell Protection Product
Table 112. Genentech Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 113. Genentech Recent Developments
Table 114. Novo Nordisk Company Details
Table 115. Novo Nordisk Business Overview
Table 116. Novo Nordisk Pancreatic Beta-Cell Protection Product
Table 117. Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 118. Novo Nordisk Recent Developments
Table 119. Sanofi Company Details
Table 120. Sanofi Business Overview
Table 121. Sanofi Pancreatic Beta-Cell Protection Product
Table 122. Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 123. Sanofi Recent Developments
Table 124. Osiris Therapeutics Company Details
Table 125. Osiris Therapeutics Business Overview
Table 126. Osiris Therapeutics Pancreatic Beta-Cell Protection Product
Table 127. Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 128. Osiris Therapeutics Recent Developments
Table 129. Beta-O2 Technologies Ltd Company Details
Table 130. Beta-O2 Technologies Ltd Business Overview
Table 131. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Product
Table 132. Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 133. Beta-O2 Technologies Ltd Recent Developments
Table 134. Transition Therapeutics Company Details
Table 135. Transition Therapeutics Business Overview
Table 136. Transition Therapeutics Pancreatic Beta-Cell Protection Product
Table 137. Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
Table 138. Transition Therapeutics Recent Developments
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pancreatic Beta-Cell Protection Market Share by Type: 2021 VS 2028
Figure 2. Stem Cell Based Features
Figure 3. Gene Therapies Features
Figure 4. RNA Based Therapies Features
Figure 5. Monoclonal Antibodies (MAbs) Features
Figure 6. Phytotherapy Features
Figure 7. Global Pancreatic Beta-Cell Protection Market Share by Application: 2021 VS 2028
Figure 8. Hospital Case Studies
Figure 9. Medical Research Laboratory Case Studies
Figure 10. Others Case Studies
Figure 11. Pancreatic Beta-Cell Protection Report Years Considered
Figure 12. Global Pancreatic Beta-Cell Protection Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Pancreatic Beta-Cell Protection Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Pancreatic Beta-Cell Protection Market Share by Region: 2021 VS 2028
Figure 15. Global Pancreatic Beta-Cell Protection Market Share by Players in 2021
Figure 16. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Beta-Cell Protection as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Pancreatic Beta-Cell Protection Revenue in 2021
Figure 18. North America Pancreatic Beta-Cell Protection Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2028)
Figure 20. North America Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2028)
Figure 21. North America Pancreatic Beta-Cell Protection Market Size Share by Country (2017-2028)
Figure 22. United States Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Pancreatic Beta-Cell Protection Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2028)
Figure 26. Europe Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2028)
Figure 27. Europe Pancreatic Beta-Cell Protection Market Size Share by Country (2017-2028)
Figure 28. Germany Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Pancreatic Beta-Cell Protection Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Pancreatic Beta-Cell Protection Market Size Share by Region (2017-2028)
Figure 38. China Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Pancreatic Beta-Cell Protection Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Pancreatic Beta-Cell Protection Market Size Share by Country (2017-2028)
Figure 48. Mexico Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Pancreatic Beta-Cell Protection Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Pancreatic Beta-Cell Protection Market Size Share by Country (2017-2028)
Figure 54. Turkey Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. ViaCyte Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 58. PharmaCyte Biotech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 60. GalaxoSmithKline Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 61. Beta-Cell NV Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 62. Novartis Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 63. Janssen Research & Development Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 64. Pfizer Inc Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 65. BioLineRx Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 66. Genentech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 67. Novo Nordisk Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 68. Sanofi Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figure 69. Osiris Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
Figur
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs